# K930529: Benzodiazepine Enzyme Immunoassay

- Pathway: 510(k) (Traditional)
- Applicant: Diagnostic Reagents, Inc.
- Decided: Aug 5, 1993 after 184 days
- Product code: JXM (Enzyme Immunoassay, Benzodiazepine)
- Device class: 2
- Regulation: 21 CFR 862.3170
- Recalls of this device: none
- Data: FDA decisions to Oct 25, 2026; recalls to Oct 12, 2026

## Lineage
No predicates in its family tree.
5 later devices descend from it; 2 cite it directly.
0 of 6 devices in its family (counting itself) have a Class I recall.

## Predicates on the family tree (from the FDA summary)
- None. FDA lists a 510(k) statement for it but has not posted the file, so its predicates are not known.

## Most influential descendants
- K173963: DRI Benzodiazepine Assay (2018), 3 descendants of its own
- K182719: Quidel Triage TOX Drug Screen, 94600; Quidel Triage® MeterPro (2019), 1 descendant of its own
- K243498: Alinity c Benzodiazepines Reagent Kit (2024), 0 descendants of its own
- K200363: Quidel Triage® TOX Drug Screen, 94600 (2020), 0 descendants of its own
- K151771: Immunalysis Benzodiazepines Urine Enzyme Immunoassay, Immunalysis Multi-Drug Calibrators (2016), 0 descendants of its own

Source page: https://510kreport.com/device/K930529
Methodology: https://510kreport.com/methodology